SYNGENE — Syngene International Share News
0.000.00%
- IN₹167.75bn
- IN₹160.76bn
- IN₹37.39bn
Brief: Syngene International Sept-Quarter Consol Profit 322 Million Rupees
India's Syngene International slides to 6-year low on Q1 loss, full-year forecast
Brief: Syngene International Posts June-Quarter Consol Loss 90 Million Rupees
Brief: Syngene International Says Granted Tax Refund Of 86.2 Million Rupees
Brief: Syngene International Appoints Siddharth Mittal As MD, CEO
Brief: India's Syngene International Posts March-Qtr Consol Profit 1.48 Billion Rupees
Brief: Syngene Names Siddharth Mittal As Additional Director, Designated As MD& CEO
Brief: Syngene International Ltd Says Partial Relief Granted To Company In Tax Appeals
India's Syngene International falls to four-year low after Jefferies' downgrade
India's Syngene International slips after quarterly profit drop
Brief: Syngene International Ltd Dec-Quarter Consol Profit 150 Million Rupees
Indian drugmaker Divi's beats profit view for second quarter on API boost
Brief: Syngene International Sept-Quarter Consol Profit 671 Million Rupees
Brief: Syngene International June-Quarter Consol Profit 867 Mln Rupees
Brief: Syngene International Gets Establishment Inspection Report From USFDA
India's Syngene International set for record intraday fall on Q4 profit drop, weak outlook
Brief: Syngene International March-Quarter Consol Profit 1.83 Bln Rupees
Brief: Syngene International Says National Faceless Assessment Centre Drops Penalty Proceedings For 33.6 Million Rupees
Brief: Syngene International Gets Tax Demand Order For 2.4 Million Rupees